STAT: Covid-19 booster shot distribution chance to fix rollout flaws
News that Covid-19 booster shots are in America’s future has given rise to bad memories surrounding the initial rollout. UC College of Law professor Jennifer Bard says that President Biden’s decision that everyone be equally eligible for a booster shot eight months after the initial shot risks reproducing many of the flaws, challenges and problems that plagued the first rollout — leading to inequity in vaccine distribution.
Professor Jennifer Bard
In the editorial “Covid-19 booster shot distribution must learn from vaccine roll-out mistakes,” co-authored by Bard and Chloe Reichel, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and editor-in-chief of its Bill of Health blog, the two discuss the challenges of the initial vaccine rollout, strategies to avoid them moving forward, the importance of transparency about potential side effects, and the proactive steps that should be taken to address community concerns. Their solutions include creating an evidence-based framework for distributing booster shots, recoding vaccinations, providing ready access to vaccination records, and addressing adverse effects.
STAT provides in-depth biotech, pharma, policy, and life science coverage and analysis.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.